Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Accounts Payables (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Accounts Payables for 6 consecutive years, with $6274.0 as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 23.73% to $6274.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6274.0 through Dec 2025, down 23.73% year-over-year, with the annual reading at $6274.0 for FY2025, 23.73% down from the prior year.
  • Accounts Payables for Q4 2025 was $6274.0 at BioScience Health Innovations, down from $10165.0 in the prior quarter.
  • The five-year high for Accounts Payables was $16636.0 in Q2 2025, with the low at $760.0 in Q1 2021.
  • Average Accounts Payables over 5 years is $6834.4, with a median of $6355.0 recorded in 2022.
  • The sharpest move saw Accounts Payables soared 736.18% in 2022, then tumbled 72.22% in 2024.
  • Over 5 years, Accounts Payables stood at $3284.0 in 2021, then fell by 12.7% to $2867.0 in 2022, then surged by 167.7% to $7675.0 in 2023, then rose by 7.18% to $8226.0 in 2024, then fell by 23.73% to $6274.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $6274.0, $10165.0, and $16636.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.